CDKN2B-AS1 in LC cases presented high expression and dropped after therapy (P < 0.05), and the opposite situation of miR-199a-5p was found in the LC cases (P < 0.05). The gene discussed is CDKN2B; the disease is laryngotracheoesophageal cleft.